Relax and do not fret. Ensure that you get enough rest.
If you have been prescribed medicines by your doctor, continue taking them. This is usually progesterone which is needed to let the pregnancy lead to best outcome.
Continue to eat healthily. Incorporate protein, calcium, vitamin B and iron in your diet.
Start taking folic acid supplements.
Keep away from plastics and substances that contain bisphenol A, phthalates, parabens and triclosan. These are called endocrine-disrupting chemicals (EDCs) and can interfere with the child’s organ development.
Don’t
You might feel some pelvic discomfort and belly fullness may persist for a week or more after the eggs are retrieved. Don’t panic as it will heal with time.
Avoid strenuous physical activity such as running, intense workout, aerobics, and cycling.
Don’t ignore symptoms that are related to ovarian hyperstimulation syndrome (OHSS) such as abdominal pain and bloating, nausea, vomiting, and diarrhoea.
*Zero Interest EMI Plans: Provided by third party financial institution, subject to conditions.
*72%+ Success Rate: Overall IVF success rate is calculated as the total number of positive pregnancy blood tests resulting from IVF procedures at our own and operated clinics in India divided by the total number of pregnancy blood tests reported from IVF procedures at our own and operated clinics in India during financial year ending 31st March 2025.
*Best IVF/Fertility Chain of the Year: Received the “Best IVF/Fertility Chain of the Year – National” award at the IVF Excellence Awards by Voice of Healthcare, 2024.
*Most Trusted IVF Chain: Received the “Most Trusted IVF Chain” award by The Knights – MY FM Group, 2019.
* Please note: The information provided on website serves as a general guide and does not constitute medical advice. We strongly advise consulting a certified fertility expert for professional assessment and personalized treatment recommendations.
*Indira IVF is the Largest IVF Chain of Hospitals: India’s largest IVF service provider by the number of clinics and in terms of revenue and EBITDA among the peers in the consideration set comprising single specialty IVF players in Financial Year 2024, according to the report titled ‘Assessment of the healthcare delivery sector in India with focus on ART healthcare market’ issued by CRISIL Market Intelligence & Analytics in January 2025.